Orbito Asia

What Orbito Asia does

OrbitoAsia Diagnostics (Orbito Asia) is a Coimbatore-headquartered, privately held diagnostic services company operating across South India and select metros. Founded in 2013, it provides integrated pathology, medical imaging, genomics, and molecular diagnostics through 20+ owned and franchise diagnostic centers spanning Tamil Nadu, Karnataka, Maharashtra, Telangana, Kerala, Odisha, and Andhra Pradesh, complemented by home sample collection services in 16+ cities. The core technology platform combines clinical pathology, molecular biology, genomics, and medical imaging on automated analyzers with a bi-directional Laboratory Information System (LIS) interface. Its product portfolio includes 10 tiered preventive health check-up packages (Orbito Basics through Orbito Optimals, priced INR 800-6,000), full imaging services (MRI, CT, X-Ray, BMD, Ultrasound, ECG, Echo, TMT, Mammogram, OPG, CBCT), and a 4,500+ test menu spanning routine to super-specialized diagnostics, including advanced molecular platforms such as BioFire FilmArray, Multiplex Real-Time PCR, Illumina MiniSeq, and Oxford Nanopore sequencing. Two specialized sub-brands — Freda Mom & Baby (prenatal genomics including NIPS, QF-PCR, Chromosomal Microarray, and newborn screening) and UNIQ Infection (40+ multiplex infectious disease panels covering sepsis, respiratory, meningitis, CNS, and gastroenteritis) — anchor its differentiated molecular diagnostics positioning.

The business operates five distinct revenue streams: per-test diagnostic service fees (transaction-based), franchise licensing fees, Hospital Lab Management (HLM) managed-service contracts with partner hospitals, corporate wellness programs (per-employee B2B pricing), and clinical research support services for pharmaceutical trials. Customer segments span individual consumers (direct-to-consumer via walk-in, website, WhatsApp, and home collection), corporate clients, franchisees, and hospital partners such as Alva Hospital, Saran's Hospital, Uma Hospital, and Kavin Hospital in Tamil Nadu. The company holds NABL, CAP, and ISO 15189:2022 accreditations, with ICH-GCP and GLP compliance for its clinical research operations. Pricing is pay-as-you-go in INR with free home sample collection bundled into health packages and 24-hour report turnaround on most tests. The company employs 101-250 staff and has cumulatively processed 5+ million tests, including 2+ million COVID-19 tests.

Name

Orbito Asia

Legal name

OrbitoAsia Diagnostics

Website

https://orbitoasia.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

OrbitoAsia Diagnostics is a Coimbatore-headquartered Indian diagnostic services company operating 20+ centers and home collection across South India, offering integrated pathology, imaging, genomics, and molecular diagnostics to individual consumers, hospitals, corporates, and franchisees.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Diagnostic laboratory services
• Pathology and imaging
• Preventive health packages
• Hospital lab management
• Genomics and prenatal testing

Headquarters

HQ city

Coimbatore

HQ country

India

HQ region

Asia

Offices16 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Revenue generated from individual diagnostic tests and health check-up packages spanning routine to super-specialized tests. Services include pathology (biochemistry, microbiology, hematology, immunology, serology, clinical pathology, molecular biology, genomics, oncology) and medical imaging (MRI, CT, X-Ray, Ultrasound, Mammogram, BMD, OPG, CBCT, ECG, Echo, TMT). Customers pay per test or package, with home collection, walk-in, and corporate on-site delivery options.
2. Franchise Fees: Franchise partners pay for the right to use the OrbitoAsia brand, business model, and operational framework. Franchise opportunities offered to individuals and businesses interested in joining the network and replicating the diagnostic business model locally.
3. Hospital Lab Management (HLM): Comprehensive green lab management offering where OrbitoAsia manages complete laboratory operations for partner hospitals including staffing, equipment maintenance, quality assurance, and regulatory compliance. Revenue generated through service contracts with healthcare facilities.
4. Corporate Wellness Programs: B2B services including pre-employment check-ups, annual health check-ups, on-site health screenings, COVID-19 testing, doctor consultations, and wellness intervention programs for corporate clients. Revenue generated through per-employee or per-package pricing with enterprise clients.
5. Clinical Research Support: Supports pharmaceutical trials, medical device studies, and observational research. Services include regulatory compliance, on-site monitoring, data management, investigator training, and protocol-specific pathology, cardiology and radiology services for clinical trial requirements.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels7 records

Core offering

OrbitoAsia Diagnostics operates a centralized pathology and imaging laboratory delivering over 4,500 diagnostic tests across biochemistry, microbiology, histopathology, hematology, immunology, molecular biology, genomics, and oncology, alongside radiology (MRI, CT, X-Ray, BMD, Ultrasound, Mammogram) and cardiology (ECG, Echo, TMT) imaging. The company serves individual consumers through preventive health packages and home sample collection, corporate clients through wellness programs, and hospitals through outsourced Laboratory Information System (LIS) integrated lab management. It also operates specialized sub-brands (Freda Mom & Baby for genomics/prenatal testing and UNIQ Infection for syndromic infectious disease panels) and a franchise network across South India.

Product overview

OrbitoAsia Diagnostics is a comprehensive pathology lab and diagnostic center offering a unified platform of medical diagnostic services. The core portfolio spans preventive health checkup packages (Orbito Basics, Initials, Fundamentals, Essentials, Essential Life, Cardio-Diabetic Type II, Thyroid, Auto Immune, Pink, and Optimals), advanced imaging services (MRI, CT, X-Ray, BMD, Ultrasound, ECG, Echo, TMT), laboratory services (biochemistry, microbiology, histopathology, hematology, immunology, genomics, oncology), and specialized sub-brands including Freda Mom & Baby for genomics/prenatal testing and UNIQ Infection for infectious disease panels. Supporting services include Home Healthcare, Hospital Lab Management, Corporate Wellness Programs, and Clinical Research Support. The company operates across multiple locations in South India with NABL and CAP accreditation.

Differentiator

Problem solved

Functional benefit

Products and services

• Freda Mom & Baby - Genomics Services
• UNIQ Infection - Infectious Disease Panels
• Laboratory Services
• MRI Scan Service
• CT Scan Service
• X-Ray Service
• BMD (Bone Mineral Density) Service
• Ultrasound Service
• Cardiology Services (ECG, Echo, TMT)
• Home Healthcare Services
• Hospital Lab Management (HLM)
• Corporate Wellness Program
• Clinical Research Support
• Orbito Basics Health Package
• Orbito Initials Health Package
• Orbito Fundamentals Health Package
• Orbito Essentials Health Package
• Orbito Essential Life Health Package
• Orbito Cardio-Diabetic Type II Package
• Orbito Thyroid Package
• Orbito Auto Immune Package
• Orbito Pink Package
• Orbito Optimals Package
• RightPath Newborn Screening
• NIPS (Non-Invasive Prenatal Screening)
• OrbitoAsia Franchise Program

Quantifiable outcome

• 5 million+ tests successfully handled in clinical diagnostic programs
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Partnerships

13 partnerships are on record, tiered minor and core.

• Nehru CollegeminorStrategic or Co-development Partner · 1 January 2024Academic MoU for internship program enabling college students to undertake training at OrbitoAsia's diagnostic facilities.
• Bharathiyar UniversityminorStrategic or Co-development PartnerAcademic partnership involving MoU for internship and training programs. Students from Bharathiyar University participate in internship programs at OrbitoAsia Diagnostics, gaining hands-on experience in diagnostic laboratory operations.
• AJK CollegeminorStrategic or Co-development PartnerAcademic partnership MoU for student internship and training at OrbitoAsia Diagnostics laboratory and imaging facilities.
• Ramakrishana CollegeminorStrategic or Co-development Partner7-day internship program for students at OrbitoAsia Diagnostics facilities.
• Rathinam College of Art and ScienceminorStrategic or Co-development Partner7-day internship program for students at OrbitoAsia Diagnostics facilities.
• Dr. G.R.D. College of ScienceminorStrategic or Co-development Partner7-day internship program for science students at OrbitoAsia Diagnostics facilities.
• Karpagam College of Higher EducationminorStrategic or Co-development Partner15-day internship program for students at OrbitoAsia Diagnostics laboratory facilities.
• Avinashilingam College of Home Science for Higher EducationminorStrategic or Co-development Partner7-day internship program for students at OrbitoAsia Diagnostics facilities.
• Kalaignar Karunanidhi Institute of TechnologyminorStrategic or Co-development Partner15-day internship program for technology institute students at OrbitoAsia Diagnostics.
• Alva HospitalcoreStrategic or Co-development PartnerHospital Lab Management partnership where OrbitoAsia manages the laboratory operations at Alva Hospital's Samathur location in Pollachi, including staffing, equipment, quality assurance, and regulatory compliance.
• Saran's HospitalcoreStrategic or Co-development PartnerHospital Lab Management partnership at Coimbatore (Pappanaickenpalayam) and Madurai (Ponmeni) locations. OrbitoAsia provides comprehensive laboratory management services.
• Uma HospitalcoreStrategic or Co-development PartnerHospital Lab Management partnership at Komarapalayam location where OrbitoAsia manages complete laboratory operations.
• Kavin HospitalcoreStrategic or Co-development PartnerHospital Lab Management partnership at Bhavani location.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Suburban Diagnostics: Maharashtra-based regional diagnostic chain offering integrated pathology and imaging plus corporate wellness and home collection — operationally and structurally analogous to OrbitoAsia but anchored in western India.
• Vijaya Diagnostic Centre: Strong regional diagnostic player headquartered in Hyderabad with deep penetration across Telangana and Andhra Pradesh — geographically adjacent to and partially overlapping with OrbitoAsia's South India branch network.
• Medinova Diagnostic Services: South India-based diagnostic chain offering pathology, imaging, and home collection services; competes for similar tier-2 South Indian patients and corporate wellness accounts in overlapping catchments.
• Aarthi Scans: South India imaging-focused diagnostic chain with strong radiology presence in Tamil Nadu and neighboring states, competing for the same imaging customer base (MRI/CT/X-ray/Ultrasound) that OrbitoAsia serves.

Direct peers

• Apollo Diagnostics: Hospital-affiliated pan-India diagnostic chain leveraging the Apollo Hospitals brand, offering pathology and imaging services comparable to OrbitoAsia's full-service model, including corporate wellness and B2B hospital outsourcing.
• Metropolis Healthcare: National Indian diagnostic chain with strong focus on specialized and advanced diagnostics, including molecular and genomic testing — overlapping directly with OrbitoAsia's advanced panels and genomics positioning across major cities.
• Neuberg Diagnostics: Growing diagnostic chain with explicit focus on advanced molecular, genomic, and super-specialty testing — directly overlapping OrbitoAsia's genomics, NIPS, and infectious disease multiplex panel portfolio across South India.
• Agilus Diagnostics (formerly SRL Diagnostics): Pan-India diagnostic chain operated as a joint venture with Fortis, with a strong Hospital Lab Management (HLM) franchise directly comparable to OrbitoAsia's HLM offering. Competes across routine and specialized diagnostics nationwide.
• Dr. Lal PathLabs: India's largest national diagnostic chain, offering comprehensive pathology and preventive health packages directly comparable to OrbitoAsia's core service line. Operates a nationwide network including South India, competing head-to-head in routine and specialized testing.
• Thyrocare Technologies: Pioneer of preventive health check-up packages in India and leader in low-cost, high-volume routine diagnostics. Competes directly with OrbitoAsia's Orbito Basics, Initials, Fundamentals, and Essentials preventive packages on price and turnaround.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/orbitoasia

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orbito Asia